NOVEL COMBINATION OF CYCLOPHOSPHAMIDE, TOPOTECAN AND NAXITIMAB FOR RELAPSED REFRACTORY NEUROBLASTOMA

被引：0
|
作者：
Brown, Lauren [1 ]
Phillips, Katlin [1 ]
Michael, Meghan [1 ]
Oesterheld, Javier [1 ]
Sholler, Giselle Saulnier [1 ]
Trovillion, Erin [1 ]
机构：
[1] Atrium Hlth, Levine Childrens Hosp, Charlotte, NC USA
来源：
PEDIATRIC BLOOD & CANCER | 2023年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
252
引用
收藏
页码：S114 / S115
页数：2
相关论文
共 50 条
  • [1] A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma
    Eslin, Don
    Zage, Peter E.
    Bergendahl, Genevieve
    Lewis, Elizabeth
    Roberts, William
    Kraveka, Jacqueline
    Mitchell, Deanna
    Isakoff, Michael S.
    Rawwas, Jawhar
    Wada, Randal K.
    Fluchel, Mark
    Brown, Valerie I.
    Ginn, Kevin
    Higgins, Timothy
    BeeravallyNagulapally, Abhinav
    Dykema, Karl
    Hanna, Gina
    Ferguson, William
    Saulnier Sholler, Giselle L.
    INTERNATIONAL JOURNAL OF CANCER, 2023, 153 (05) : 1026 - 1034
  • [2] Evaluation of palbociclib in combination with topotecan and cyclophosphamide in pediatric patients with recurrent or refractory neuroblastoma
    Laetsch, Theodore Willis
    Navid, Fariba
    Weigel, Brenda
    Fox, Elizabeth
    Hawkins, Douglas S.
    Muscal, Jodi Ann
    Juszczak-Kosela, Katarzyna Alicja
    Zhang, Zhe
    Macy, Margaret E.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Gefitinib in Combination With Oral Topotecan and Cyclophosphamide in Relapsed Neuroblastoma: Pharmacological Rationale and Clinical Response
    Donfrancesco, Alberto
    De Ioris, Maria Antonietta
    McDowell, Heather Prudence
    De Pasquale, Maria Debora
    Ilari, Ilaria
    Jenkner, Alessandro
    Castellano, Aurora
    Cialfi, Samantha
    De Laurentis, Clementina
    Dominici, Carlo
    PEDIATRIC BLOOD & CANCER, 2010, 54 (01) : 55 - 61
  • [4] GEFITINIB IN COMBINATION WITH ORAL TOPOTECAN AND CYCLOPHOSPHAMIDE IN RELAPSED NEUROBLASTOMA: PHARMACOLOGICAL RATIONALE AND CLINICAL RESPONSE
    De loris, Maria Antonietta
    Donfrancesco, Alberto
    PEDIATRIC BLOOD & CANCER, 2009, 53 (05) : 808 - 808
  • [5] Topotecan and cyclophosphamide in patients with refractory or relapsed Ewing tumors
    Hunold, Andrea
    Weddeling, Nicole
    Paulussen, Michael
    Ranft, Andreas
    Liebscher, Caren
    Juergens, Herbert
    PEDIATRIC BLOOD & CANCER, 2006, 47 (06) : 795 - 800
  • [6] Oral topotecan for refractory and relapsed neuroblastoma: A retrospective analysis
    Kramer, K
    Kushner, BH
    Cheung, NKV
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 (08) : 601 - 605
  • [7] ORAL THERAPY WITH TOPOTECAN, CYCLOPHOSPHAMIDE AND GEFITINIB IN RESISTANT AND/OR RELAPSED NEUROBLASTOMA
    De Loris, M. A.
    Ilari, I.
    De Pasquale, M. D.
    Pessolano, R.
    Castellano, A.
    Jenkner, A.
    Cozza, R.
    De Sio, L.
    De Laurentis, C.
    Fidani, P.
    Serra, A.
    Dominici, C.
    Donfrancesco, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : S8 - S8
  • [8] Modified topotecan combination with cyclophosphamide and ara-c (CAT) for patients with Refractory/Relapsed leukemia
    Wu, Sui-jing
    Du, Xin
    Lin, Wei
    Huang, Zi-lun
    Zhou, Xiao-li
    Weng, Jian-yu
    Zhong, Li-ye
    Lu, Ze-sheng
    BLOOD, 2007, 110 (11) : 157B - 157B
  • [9] A phase 1 dose-escalation study of LY3295668 erbumine as monotherapy and in combination with topotecan and cyclophosphamide in children with relapsed/refractory neuroblastoma
    DuBois, Steven G.
    Ogawa, Chitose
    Moreno, Lucas
    Mosse, Yael P.
    Fischer, Matthias
    Ryan, Anne L.
    Vo, Kieuhoa T.
    De Wilde, Bram
    Rubio-San-Simon, Alba
    Macy, Margaret E.
    Howell, Lisa
    Shusterman, Suzanne
    Corradini, Nadege
    Luksch, Roberto
    Aerts, Isabelle
    Foster, Jennifer H.
    Weiss, Brian D.
    Karthik, Chandrasekhar Pamidipati
    Yuen, Eunice
    Avsar, Emin
    Park, Julie R.
    Marachelian, Araz
    CANCER, 2025, 131 (04)
  • [10] Phase I trial of lorlatinib in combination with topotecan/cyclophosphamide in children with ALK-driven refractory or relapsed neuroblastoma: A new approaches to neuroblastoma therapy consortium study.
    Goldsmith, Kelly C.
    Mosse, Yael P.
    Kayser, Kimberly
    Chi, Yueh-Yun
    Chioda, Marc
    Thurm, Holger C.
    Chen, Joseph
    Krishnaswami, Sriram
    Peltz, Gerson
    Granger, Meaghan
    Mody, Rajen
    Marshall, Lynley V.
    Desai, Ami Vijay
    Berko, Esther
    Maris, John M.
    Matthay, Katherine K.
    Ghazarian, Suzy
    Park, Julie R.
    Marachelian, Araz
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345